SCHEMBL6207220

SCHEMBL6207220

CN(C)C(=O)C1CC=NO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8596836 0.66 — —
SCHEMBL8148198 0.64 — —
SCHEMBL14024079 0.63 NPC1 (0.35) —
SCHEMBL19872985 0.63 NPC1 (0.35) —
SCHEMBL2536297 0.61 — —
SCHEMBL28280261 0.60 — —
SCHEMBL2533313 0.60 — —
SCHEMBL3832712 0.60 DPP4 (0.34) —
SCHEMBL2918826 0.59 — —
SCHEMBL24127282 0.58 BCHE (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115160305-A Amide compound containing 4, 5-dihydroisoxazole, salt thereof, preparation method and application 华东理工大学 2022-10-11 — — CN disclosed
EP-1567532-A1 OXAZOLIDINONE AND / OR ISOXAZOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS Astrazeneca AB (SE) 2005-08-31 — — EP disclosed
WO-2004048392-A1 OXAZOLIDINONE AND / OR ISOXAZOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS ASTRAZENECA AB (SE) 2004-06-10 — — WO disclosed
Send feedback